NCT07151820View on ClinicalTrials.gov

A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients

CompletedOBSERVATIONAL
Enrollment

2,546

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

October 22, 2024

Study Completion Date

October 22, 2024

Conditions
Leukemia, Chronic Myeloid
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT07151820 - A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients | Biotech Hunter | Biotech Hunter